Skip to search formSkip to main contentSkip to account menu

Pulmonary Hypertension

Known as: Pulmonary hypertension NOS, pulmonary hypertension disorder, Hypertension, Pulmonary 
Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Nazzareno Galiè (ESC Chairperson), Marc Humbert (ERS Chairperson), Jean-Luc Vachiery, Simon Gibbs, Irene Lang, Adam Torbicki, G… 
Highly Cited
2007
Highly Cited
2007
2007 Guidelines for the Management of Arterial Hypertension : The Task Force for the Management of Arterial Hypertension of the… 
Highly Cited
2005
Highly Cited
2005
BACKGROUND Sildenafil inhibits phosphodiesterase type 5, an enzyme that metabolizes cyclic guanosine monophosphate, thereby… 
Highly Cited
2003
Highly Cited
2003
"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure… 
Highly Cited
2002
Highly Cited
2002
A BSTRACT Background Endothelin-1 is a potent vasoconstrictor and smooth-muscle mitogen. In a preliminary study, the orally… 
Review
1998
Review
1998
Primary pulmonary hypertension (PPH) is a progressive disease characterised by raised pulmonary vascular resistance, which… 
Highly Cited
1996
Highly Cited
1996
BACKGROUND Primary pulmonary hypertension is a progressive disease for which no treatment has been shown in a prospective… 
Highly Cited
1993
Highly Cited
1993
BACKGROUND Pulmonary hypertension is characterized by an increase in vascular tone or an abnormal proliferation of muscle cells… 
Highly Cited
1991
Highly Cited
1991
OBJECTIVE To characterize mortality in persons diagnosed with primary pulmonary hypertension and to investigate factors… 
Highly Cited
1987
Highly Cited
1987
A national registry was begun in 1981 to collect data from 32 centers on patients diagnosed by uniform criteria as having primary…